From the FDA Consumer Magazine, March-April 2005 by Carol Rados
Few people with arthritis would be willing to stop taking a medication that works, especially when nothing else has. But what if joint pain and stiffness are inevitable if you don't take the medication, yet heart problems could occur if you do? Health officials say that, as with any drug, only you and your doctor can determine the level of risk that is acceptable with medications currently available to treat arthritis.
The...
Read moreRecently, a brand new medication was approved for use in the United States by the Food & Drug Administration (FDA, for short). The... Read more »
Someone once asked my about the impact of Migraine disease on my life -- what was the worst thing about it? An interesting question, an... Read more »
If you are taking Boniva® monthly medication for your osteoporosis and finding it very expensive, or your insurance doesn't cover... Read more »
I have good news for those of you who depended on Midrin for Migraines or tension-type headaches. I've confirmed that Macoven... Read more »
At our latest monthly MS Town Hall meeting, our excellent nurse practitioner discussed health insurance and how to get it and to remember... Read more »
A new cholesterol-lowering drug called Livalo is now available in the United States, its maker Eli Lilly is reporting. Livalo was approved by the... Read more »
Source: ADAM Encyclopedia
Surgery and Invasive ProceduresThe health care provider should give patients complete information on the expected course of their low back pain and... Read more »
A new topical pain treatment for osteoarthritis (OA) called Pennsaid is now available in the United States, its maker reports. Pennsaid is a... Read more »
Social anxiety disorder cannot be cured. Medications are available and have been found to be helpful for some people. Medications sometimes will... Read more »
Patients who take Ultram (tramadol) several times a day to manage chronic pain now have the option of an extended-release form of the drug. The new... Read more »